DrugDashboards

Market view

fluvoxamine maleate · Tablet

33 marketed package NDCs · 7 active manufacturers

Most dispensed: 100 mg · Capsule, Extended Release · #30 capsule, extended releases/bottle · 150 mg · Capsule, Extended Release · #30 capsule, extended releases/bottle · 100 mg · Tablet · #100 tablets/bottle · 25 mg · Tablet · #100 tablets/bottle

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 16% over the past year, to $0.1973 per unit.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$0.2$0.4$0.6Nov 2013Sep 202607companies actively selling

Latest · Sep 2026 — typical price $0.1973 · middle half $0.1565$0.2347 · full range $0.1429$0.2472 · 6 products · 7 companies

middle half of companies’ pricestypical (median) pricewhat manufacturers charge wholesalers (WAMP)companies actively selling (bottom lane)Priced per unitSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for fluvoxamine maleate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Mfr entered
    Upsher-Smith Laboratories, LLC · fluvoxamine maleate
  • Mfr entered
    Upsher-Smith Laboratories, LLC · fluvoxamine maleate
  • New product
    Upsher-Smith Laboratories, LLC
  • New product
    Upsher-Smith Laboratories, LLC
  • Price up
    NADAC $0.24358 → $0.24716 per unit (+1.47%)
  • Price up
    NADAC $0.14178 → $0.14293 per unit (+0.81%)
  • Price up
    NADAC $0.24358 → $0.24716 per unit (+1.47%)
  • Price down
    NADAC $0.19987 → $0.19734 per unit (-1.27%)
  • Price up
    NADAC $0.14178 → $0.14293 per unit (+0.81%)
  • Price down
    NADAC $4.99259 → $4.60851 per unit (-7.69%)

Same drug class

Other molecules FDA puts in Serotonin Reuptake Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Fluvoxamine maleate in shortage right now?
No. FDA does not currently list Fluvoxamine maleate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Fluvoxamine maleate?
25 companies have marketed Fluvoxamine maleate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Fluvoxamine maleate cost?
The typical pharmacy pays about $0.2472 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.